Tai Ching Ho

Tai Ching Ho

Nessuna posizione attualmente
64 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Tai Ching Ho is the founder of two companies.
He founded BeiGene Ltd. in 2010 and served as President from 2010 to 2012.
He also founded Metastagen, Inc. in 2013 and served as Chief Executive Officer from 2013 to 2014.
Dr. Ho held several former jobs, including Vice President-Oncology Development at Johnson & Johnson from 2008 to 2010, Chief Medical Officer & Executive Vice President at Epizyme, Inc. from 2015 to 2017, and Senior Vice President-Oncology Center at GlaxoSmithKline LLC.
He was also Chief Medical Officer at Boston Pharmaceuticals, Inc. from 2018 to 2020 and Independent Director at Aravive, Inc. from 2021 to 2024.
Dr. Ho received his undergraduate degree from The Johns Hopkins University and his doctorate from Yale School of Medicine.

Precedenti posizioni note di Tai Ching Ho

SocietàPosizioneFine
ARAVIVE, INC. Direttore/Membro del Consiglio 17/01/2024
Direttore Tecnico/Scientifico/R&S 01/01/2020
EPIZYME, INC. Direttore Tecnico/Scientifico/R&S 31/12/2017
Amministratore Delegato 01/09/2014
BEIGENE LTD Fondatore 01/12/2012
Vedi nel dettaglio l'esperienza di Tai Ching Ho

Formazione di Tai Ching Ho

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

46

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Tai Ching Ho